Abstract
Metabolic bone disease encompasses a number of disorders that typically show involvement of the entire skeleton. They are mostly associated with increased bone turnover and increased uptake of radiolabeled diphosphonate. The increased uptake produces heightened contrast on bone scan between bone and soft tissues, deceptively giving the appearance of excellent image quality. In more severe cases, there may be characteristic patterns of abnormality, including one or more of the following metabolic features [1]:
-
1.
Increased tracer uptake in the long bones
-
2.
Increased tracer uptake in the axial skeleton
-
3.
Increased uptake in the periarticular areas
-
4.
Faint or almost absent kidney images
-
5.
Prominent calvaria and mandibule
-
6.
Beading of the costochondral junctions
-
7.
“Tie” sternum
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Fogelman I, Citrin DL, Turner JG et al (1979) Semiquantitative interpretation of the bone scan in metabolic bone disease. Eur J Nucl Med 4:287–289
Weighmann T, Rosenthall L, Kaye M (1977) Technetium 99m pyrophosphate bone scan in hyperparathyroidism. J Nucl Med 18:231
Fogelman I, McKillop JH, Bessant RG et al (1978) The role of bone scanning in osteomalacia. J Nucl Med 19:245–248
Sy WM (1981) Osteoporosis. In: Sy WM (ed) Gamma images in benign and metabolic bone disease. CRC, Boca Raiton, FL, pp 223–239
Fogelman I, Carr D (1988) A comparison between bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clin Radiol 31:321–326
Ryan PJ, Fogelman I (1994) Osteoporotic vertebral fractures. Comparison with radiography and bone scintigraphy. Radiology 190:669–672
Ryan PJ, Evans PA, Gibson T, Fogelman I (1992) Osteoporosis and chronic low back pain. A study with single photon emission computed bone scintigraphy. J Bone Miner Res 7:1455–1459
Serafini AN (1976) Paget’s disease of bone. Semin Nucl Med 6:47–58
Ryan PJ, Gibson T, Fogelman I (1992) Bone scintigraphy following pamidronate therapy for Paget’s Disease of Bone. J Nucl Med 33:1589–1593
Cook GJR, Maisey M, Fogelman I (1999) Fluorine 18 FDG PET in Paget’s disease of Bone. J Nucl Med 43:259–268
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Ryan, P.J. (2009). Metabolic Bone Disease. In: Hodler, J., Zollikofer, C.L., Von Schulthess, G.K. (eds) Musculoskeletal Diseases 2009–2012. Springer, Milano. https://doi.org/10.1007/978-88-470-1378-0_30
Download citation
DOI: https://doi.org/10.1007/978-88-470-1378-0_30
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1377-3
Online ISBN: 978-88-470-1378-0
eBook Packages: MedicineMedicine (R0)